Results

Moleculin Biotech Inc.

06/21/2021 | Press release | Distributed by Public on 06/21/2021 06:35

Moleculin Announces First Subject Enrolled and Dosed in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases